Overview

A Crossover Study to Evaluate the Efficacy of Simvastatin in Elevating HDL-C Levels in Patients With Type 2 Diabetes (0733-216)(COMPLETED)

Status:
Completed
Trial end date:
2002-10-04
Target enrollment:
Participant gender:
Summary
The purpose of this study is to see how well simvastatin raises HDL levels in patients with Type 2 Diabetes.
Phase:
Phase 3
Details
Lead Sponsor:
Merck Sharp & Dohme Corp.
Treatments:
Oxymetazoline
Simvastatin